Dorsten, Germany

Ernst Roemer

USPTO Granted Patents = 2 


Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ernst Roemer: Innovator in Terpenoid Compounds

Introduction

Ernst Roemer is a notable inventor based in Dorsten, Germany. He has made significant contributions to the field of pharmaceutical and nutraceutical formulations, particularly through his innovative work with terpenoid compounds. With a total of 2 patents, Roemer's inventions focus on the modulation of biological receptors and the treatment of various diseases.

Latest Patents

Roemer's latest patents include "Terpenoid spiro ketal compounds with LXR agonists activity, their use and formulations with them." This invention relates to compositions and methods for utilizing extracts and natural spiro triterpenoids for therapeutic purposes. The formulations are designed for both animals and humans, targeting diseases that respond to the modulation of the Liver X receptor. Additionally, he has developed a patent for "Clerodane derivatives for modulation of leukotriene receptor activity and related diseases." This patent focuses on the use of clerodane compounds against inflammatory and allergic diseases, providing novel methods for treatment and preparation of medicaments.

Career Highlights

Throughout his career, Roemer has worked with various companies, including Biotropics Malaysia Berhad. His work has been instrumental in advancing the understanding and application of terpenoid compounds in medical treatments.

Collaborations

Roemer has collaborated with notable individuals in his field, including Torsten Grothe and Marc Stadler. These partnerships have contributed to the development and success of his innovative projects.

Conclusion

Ernst Roemer's contributions to the field of terpenoid compounds and their applications in medicine highlight his role as a significant inventor. His patents reflect a commitment to advancing therapeutic treatments and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…